Q32 Bio (QTTB) EPS (Basic) Growth (3y) (2020 - 2026)
Q32 Bio (QTTB) EPS (Basic) Growth (3y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EPS (Basic) Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
-27.25% |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
139.68% |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
25.99% |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
41.58% |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
85.94% |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
14.28% |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
Q32 Bio |
177.18 Mn |
126.43 Mn |
- |
69.92% |
| Date | Value |
|---|
| Mar 31, 2026 |
69.92% |
| Dec 31, 2025 |
114.36% |
| Sep 30, 2025 |
-0.56% |
| Jun 30, 2025 |
-15.21% |
| Mar 31, 2025 |
-36.78% |
| Dec 31, 2024 |
-23.45% |
| Sep 30, 2024 |
-39.31% |
| Jun 30, 2024 |
-38.03% |
| Mar 31, 2024 |
276.81% |
| Dec 31, 2023 |
-401.96% |
| Sep 30, 2023 |
-302.80% |
| Jun 30, 2023 |
-177.62% |
| Mar 31, 2023 |
-194.09% |
| Dec 31, 2022 |
-2.94% |
| Sep 30, 2022 |
4.15% |
| Jun 30, 2022 |
5.79% |
| Mar 31, 2022 |
65.29% |
| Dec 31, 2021 |
-3.64% |
| Sep 30, 2021 |
-12.43% |
| Jun 30, 2021 |
-16.67% |
